Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): a retrospective review

BACKGROUND: Ototoxicity is a known side effect of combined radiation therapy and cisplatin chemotherapy for the treatment of medulloblastoma. The delivery of an involved field boost by intensity modulated radiation therapy (IMRT) may reduce the dose to the inner ear when compared with conventional r...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira, Wilson Albieri, Weltman, Eduardo, Chen, Michael Jenwei, da Silva, Nasjla Saba, Cappellano, Andrea Maria, Pereira, Liliane Desgualdo, Gonçalves, Maria Ines Rabelo, Ferrigno, Robson, Hanriot, Rodrigo Morais, Nadalin, Wladimir, Odone Filho, Vicente, Petrilli, Antonio Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118158/
https://www.ncbi.nlm.nih.gov/pubmed/25041714
http://dx.doi.org/10.1186/1748-717X-9-158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118158/
https://www.ncbi.nlm.nih.gov/pubmed/25041714
http://dx.doi.org/10.1186/1748-717X-9-158

Ejemplares similares